Lisa Frenkel
#181,255
Most Influential Person Now
Researcher
Lisa Frenkel's AcademicInfluence.com Rankings
Lisa Frenkelphilosophy Degrees
Philosophy
#11488
World Rank
#15823
Historical Rank
Logic
#8302
World Rank
#10364
Historical Rank
Lisa Frenkelbiology Degrees
Biology
#15254
World Rank
#19194
Historical Rank
Immunology
#1053
World Rank
#1079
Historical Rank
Download Badge
Philosophy Biology
Lisa Frenkel's Degrees
- Doctorate Medicine University of California, San Francisco
- PhD Immunology University of Washington
Why Is Lisa Frenkel Influential?
(Suggest an Edit or Addition)According to Wikipedia, Lisa M. Frenkel is an American pediatrician currently Professor at University of Washington and an Elected Fellow of the American Association for the Advancement of Science. Education She earned her B.A. at University of Kansas from 1973–77 and her M.D. at University of Kansas Medical Center from 1977-81.
Lisa Frenkel's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. (2012) (2748)
- Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection (2014) (530)
- Natural history of neonatal herpes simplex virus infections in the acyclovir era. (2001) (431)
- A population-based study of primary human herpesvirus 6 infection. (2005) (390)
- HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis (2017) (239)
- Evidence that Low-Level Viremias during Effective Highly Active Antiretroviral Therapy Result from Two Processes: Expression of Archival Virus and Replication of Virus (2005) (215)
- Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection. (1991) (211)
- Oral acyclovir suppression and neurodevelopment after neonatal herpes. (2011) (187)
- Maternal Toxicity With Continuous Nevirapine in Pregnancy: Results From PACTG 1022 (2004) (173)
- Treatment of cytomegalovirus retinopathy with ganciclovir. (1987) (161)
- Maternal viral genotypic zidovudine resistance and infrequent failure of zidovudine therapy to prevent perinatal transmission of human immunodeficiency virus type 1 in pediatric AIDS Clinical Trials Group Protocol 076. (1998) (156)
- The management of pregnancies complicated by genital infections with herpes simplex virus. (1992) (139)
- Simple, Sensitive, and Specific Detection of Human Immunodeficiency Virus Type 1 Subtype B DNA in Dried Blood Samples for Diagnosis in Infants in the Field (2001) (134)
- Blinded, Multicenter Comparison of Methods To Detect a Drug-Resistant Mutant of Human Immunodeficiency Virus Type 1 at Low Frequency (2006) (125)
- Clinical, virologic and immunologic responses of children with advanced human immunodeficiency virus type 1 disease treated with protease inhibitors. (1997) (122)
- Pharmacokinetics of acyclovir in the term human pregnancy and neonate. (1991) (112)
- Evolutionary Indicators of Human Immunodeficiency Virus Type 1 Reservoirs and Compartments (2003) (109)
- Multiple Viral Genetic Analyses Detect Low-Level Human Immunodeficiency Virus Type 1 Replication during Effective Highly Active Antiretroviral Therapy (2003) (107)
- Effects of zidovudine use during pregnancy on resistance and vertical transmission of human immunodeficiency virus type 1. (1995) (100)
- Risk of drug resistance among persons acquiring HIV within a randomized clinical trial of single- or dual-agent preexposure prophylaxis. (2015) (94)
- Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial. (2014) (91)
- Viremia in neonatal herpes simplex virus infections. (1999) (89)
- An Increasing Proportion of Monotypic HIV-1 DNA Sequences during Antiretroviral Treatment Suggests Proliferation of HIV-Infected Cells (2012) (87)
- Treatment of Cytomegalovirus Retinopathy in Patients With Acquired Immunodeficiency Syndrome: Use of the Experimental Drug 9-[2-Hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine (1986) (81)
- HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing (2015) (75)
- Specific, sensitive, and rapid assay for human immunodeficiency virus type 1 pol mutations associated with resistance to zidovudine and didanosine (1995) (75)
- Sensitive Method for Detection of Human Herpesviruses 6 and 7 in Saliva Collected in Field Studies (2000) (74)
- Oligonucleotide Ligation Assay for Detecting Mutations in the Human Immunodeficiency Virus Type 1 polGene That Are Associated with Resistance to Zidovudine, Didanosine, and Lamivudine (1998) (74)
- Genetic evaluation of suspected cases of transient HIV-1 infection of infants. (1998) (70)
- Ontogeny of phytohemagglutinin-induced gamma interferon by leukocytes of healthy infants and children: evidence for decreased production in infants younger than 2 months of age. (1987) (66)
- Interaction between lactobacilli, bacterial vaginosis-associated bacteria, and HIV Type 1 RNA and DNA Genital shedding in U.S. and Kenyan women. (2013) (63)
- Lack of Resistance to Integrase Inhibitors among Antiretroviral-Naive Subjects with Primary HIV-1 Infection, 2007–2013 (2015) (63)
- Rapid and Sensitive Oligonucleotide Ligation Assay for Detection of Mutations in Human Immunodeficiency Virus Type 1 Associated with High-Level Resistance to Protease Inhibitors (2002) (61)
- Compartmentalization of HIV-1 within the Female Genital Tract Is Due to Monotypic and Low-Diversity Variants Not Distinct Viral Populations (2009) (60)
- Pre-exposure prophylaxis for HIV-negative persons with partners living with HIV: uptake, use, and effectiveness in an open-label demonstration project in East Africa. (2017) (59)
- Maternal syphilis and vertical perinatal transmission of human immunodeficiency virus type‐1 infection (1998) (59)
- A proof-of-concept study of short-cycle intermittent antiretroviral therapy with a once-daily regimen of didanosine, lamivudine, and efavirenz for the treatment of chronic HIV infection. (2004) (59)
- Effect of pregnancy and zidovudine therapy on viral load in HIV-1-infected women. (1997) (54)
- Effect of Cessation of Zidovudine Prophylaxis to Reduce Vertical Transmission on Maternal HIV Disease Progression and Survival (2003) (54)
- Effects of CCR5-Δ32 and CCR2-64I alleles on disease progression of perinatally HIV-1-infected children: an international meta-analysis (2003) (54)
- Pharmacokinetics, safety, and 48-week efficacy of oral raltegravir in HIV-1-infected children aged 2 through 18 years. (2014) (53)
- Persistence of Human Immunodeficiency Virus Type 1 Subtype B DNA in Dried-Blood Samples on FTA Filter Paper (2004) (53)
- Monotypic Human Immunodeficiency Virus Type 1 Genotypes across the Uterine Cervix and in Blood Suggest Proliferation of Cells with Provirus (2009) (52)
- Treatment of cytomegalovirus retinopathy in patients with acquired immunodeficiency syndrome. Use of the experimental drug 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine. (1987) (51)
- Comparison of Oligonucleotide Ligation Assay and Consensus Sequencing for Detection of Drug-Resistant Mutants of Human Immunodeficiency Virus Type 1 in Peripheral Blood Mononuclear Cells and Plasma (2004) (49)
- Analysis of the maternal components of the AIDS clinical trial group 076 zidovudine regimen in the prevention of mother-to-infant transmission of human immunodeficiency virus type 1. (1997) (48)
- Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120 (2017) (45)
- Importance and detection of virus reservoirs and compartments of HIV infection. (2003) (45)
- Pre-exposure prophylaxis for HIV-negative persons with partners living with HIV: uptake, use, and effectiveness in an open-label demonstration project in East Africa (2017) (45)
- Pharmacokinetics and safety of stavudine in HIV-infected pregnant women and their infants: Pediatric AIDS Clinical Trials Group protocol 332. (2004) (44)
- HIV-1 dynamics in children. (1999) (44)
- Detection and Quantification of Human Immunodeficiency Virus Type 1 p24 Antigen in Dried Whole Blood and Plasma on Filter Paper Stored under Various Conditions (2005) (42)
- Nevirapine resistance by timing of HIV type 1 infection in infants treated with single-dose nevirapine. (2010) (42)
- Optimization of the Oligonucleotide Ligation Assay, a Rapid and Inexpensive Test for Detection of HIV-1 Drug Resistance Mutations, for Non-North American Variants (2008) (42)
- Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception (2014) (41)
- Pediatric AIDS prognosis using somatic growth velocity (1998) (40)
- Oral findings in asymptomatic (P-1) and symptomatic (P-2) HIV infected children. (1996) (40)
- Genetic Analyses of HIV-1 env Sequences Demonstrate Limited Compartmentalization in Breast Milk and Suggest Viral Replication within the Breast That Increases with Mastitis (2010) (38)
- Rapid decline of neutralizing antibodies is associated with decay of IgM in adults recovered from mild COVID-19 (2021) (37)
- A search for persistent rubella virus infection in persons with chronic symptoms after rubella and rubella immunization and in patients with juvenile rheumatoid arthritis. (1996) (37)
- Postpartum Viral Load Rebound in HIV-1–Infected Women Treated with Highly Active Antiretroviral Therapy: AIDS Clinical Trials Group Protocol A5150 (2011) (37)
- Risk of mother-to-infant transmission of HIV-1 is not reduced in CCR5/delta32ccr5 heterozygotes. (1997) (35)
- Detection of nonnucleoside reverse-transcriptase inhibitor-resistant HIV-1 after discontinuation of virologically suppressive antiretroviral therapy. (2008) (34)
- Prevalence and Impact of Minority Variant Drug Resistance Mutations in Primary HIV-1 Infection (2011) (34)
- Human immunodeficiency viruses appear compartmentalized to the female genital tract in cross-sectional analyses but genital lineages do not persist over time. (2013) (34)
- Oligonucleotide Ligation Assay Detects HIV Drug Resistance Associated With Virologic Failure Among Antiretroviral-Naive Adults in Kenya (2014) (34)
- Oral ganciclovir in children: pharmacokinetics, safety, tolerance, and antiviral effects. The Pediatric AIDS Clinical Trials Group. (2000) (33)
- Association between detection of HIV-1 DNA resistance mutations by a sensitive assay at initiation of antiretroviral therapy and virologic failure. (2010) (33)
- A highly multiplexed droplet digital PCR assay to measure the intact HIV-1 proviral reservoir (2021) (32)
- Density-Dependent Decay in HIV-1 Dynamics (2006) (32)
- The effects of zidovudine in the subset of infants infected with human immunodeficiency virus type-1 (Pediatric AIDS Clinical Trials Group Protocol 076). (1999) (30)
- Challenges in the Diagnosis and Management of Neonatal Herpes Simplex Virus Encephalitis (2005) (29)
- Effect of food and pharmacokinetic variability on didanosine systemic exposure in HIV-infected children. Pediatric AIDS Clinical Trials Group Protocol 144 Study Team. (2000) (29)
- Cytomegalovirus and Epstein–Barr virus in breast milk are associated with HIV-1 shedding but not with mastitis (2008) (29)
- Pharmacokinetics and 48-Week Safety and Efficacy of Raltegravir for Oral Suspension in Human Immunodeficiency Virus Type-1-Infected Children 4 Weeks to 2 Years of Age. (2015) (29)
- Detection and quantification of multiple drug resistance mutations in HIV-1 reverse transcriptase by an oligonucleotide ligation assay. (2001) (28)
- Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, rando (2021) (27)
- A search for persistent measles, mumps, and rubella vaccine virus in children with human immunodeficiency virus type 1 infection. (1994) (26)
- Efficacy and safety of 1-month postpartum zidovudine-didanosine to prevent HIV-resistance mutations after intrapartum single-dose nevirapine. (2010) (26)
- Primary human herpesvirus‐6 associated with an afebrile seizure in a 3‐week‐old infant (2002) (26)
- Healthy Neonates Possess a CD56-Negative NK Cell Population with Reduced Anti-Viral Activity (2013) (25)
- Clonal Expansion of Human Immunodeficiency Virus-Infected Cells and Human Immunodeficiency Virus Persistence During Antiretroviral Therapy. (2017) (25)
- Recurrent Bipolaris sinusitis following surgical and antifungal therapy. (1987) (25)
- Cross-contamination during processing of dried blood spots used for rapid diagnosis of HIV-1 infection of infants is rare and avoidable. (2010) (25)
- Diminished Human Immunodeficiency Virus Type 1 DNA Yield from Dried Blood Spots after Storage in a Humid Incubator at 37°C Compared to −20°C (2008) (25)
- Laboratory indicators of mastitis are not associated with elevated HIV-1 DNA loads or predictive of HIV-1 RNA loads in breast milk. (2007) (24)
- Simplified Paper Format for Detecting HIV Drug Resistance in Clinical Specimens by Oligonucleotide Ligation (2016) (24)
- Prevalence of Pre-antiretroviral-Treatment Drug Resistance by Gender, Age, and Other Factors in HIV-Infected Individuals Initiating Therapy in Kenya, 2013–2014 (2017) (23)
- Growth velocity assessment in paediatric AIDS: smoothing, penalized quantile regression and the definition of growth failure (2004) (23)
- Should patients with drug-resistant HIV-1 continue to receive antiretroviral therapy? (2001) (21)
- Biomarkers of inflammation in HIV-infected Peruvian men and women before and during suppressive antiretroviral therapy (2015) (21)
- Detection of HIV-1 Drug Resistance in Women Following Administration of a Single Dose of Nevirapine: Comparison of Plasma RNA to Cellular DNA by Consensus Sequencing and by Oligonucleotide Ligation Assay (2010) (21)
- Immune reconstitution after receipt of highly active antiretroviral therapy in children with advanced or progressive HIV disease and complete or partial viral load response. (2005) (21)
- Current Status of Point‐of‐Care Testing for Human Immunodeficiency Virus Drug Resistance (2017) (21)
- HIV drug resistance in mothers and infants following use of antiretrovirals to prevent mother-to-child transmission. (2013) (20)
- Transmitted HIV resistance to first-line antiretroviral therapy in Lima, Peru. (2012) (20)
- Risk of congenital cytomegalovirus infection among HIV‐exposed uninfected infants is not decreased by maternal nelfinavir use during pregnancy (2016) (20)
- A comparison of 3 regimens to prevent nevirapine resistance mutations in HIV-infected pregnant women receiving a single intrapartum dose of nevirapine. (2012) (19)
- Herpes simplex virus type 2 suppressive therapy with acyclovir or valacyclovir does not select for specific HIV-1 resistance in HIV-1/HSV-2 dually infected persons. (2011) (19)
- Low concentrations of HIV-1 DNA at birth delays diagnosis, complicating identification of infants for antiretroviral therapy to potentially prevent the establishment of viral reservoirs. (2014) (19)
- Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial. (2020) (19)
- Increased Detection of HIV-1 Drug Resistance at Time of Diagnosis by Testing Viral DNA With a Sensitive Assay (2009) (19)
- Efficacy and toxicity of antiretroviral therapy using 4 or more agents: application of a strategy for antiretroviral management in human immunodeficiency virus-infected children. (2002) (19)
- Transmission Cluster of Multiclass Highly Drug-Resistant HIV-1 Among 9 Men Who Have Sex With Men in Seattle/King County, WA, 2005-2007 (2008) (18)
- Simpler and faster Covid-19 testing: Strategies to streamline SARS-CoV-2 molecular assays (2021) (18)
- Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment (2020) (18)
- Validation of an Oligonucleotide Ligation Assay for Quantification of Human Immunodeficiency Virus Type 1 Drug-Resistant Mutants by Use of Massively Parallel Sequencing (2014) (18)
- OLA-Simple: A software-guided HIV-1 drug resistance test for low-resource laboratories (2019) (17)
- Pre-treatment HIV-drug resistance associated with virologic outcome of first-line NNRTI-antiretroviral therapy: A cohort study in Kenya (2020) (16)
- Persistence of HIV drug resistance among South African children given nevirapine to prevent mother-to-child-transmission (2017) (16)
- Intrapartum tenofovir and emtricitabine reduces low-concentration drug resistance selected by single-dose nevirapine for perinatal HIV prevention. (2009) (16)
- Rapid HIV type 1 testing of women presenting in late pregnancy with unknown HIV status in Lima, Peru. (2004) (16)
- Predictors of mortality within the first year of initiating antiretroviral therapy in urban and rural Kenya: A prospective cohort study (2019) (15)
- Effectiveness of antenatal group HIV voluntary counseling and testing services in rural India. (2007) (15)
- Increasing HIV-1 pretreatment drug resistance among antiretroviral-naïve adults initiating treatment between 2006 and 2014 in Nairobi, Kenya (2016) (15)
- Evaluation of the management of pretreatment HIV drug resistance by oligonucleotide ligation assay: a randomised controlled trial. (2019) (15)
- Case report: primary human herpesvirus-6 associated with an afebrile seizure in a 3-week-old infant. (2002) (14)
- Pharmacokinetics of Dapsone Administered Daily and Weekly in Human Immunodeficiency Virus-Infected Children (1999) (14)
- Safety and efficacy at 240 weeks of different raltegravir formulations in children with HIV-1: a phase 1/2 open label, non-randomised, multicentre trial. (2018) (13)
- Short Communication: Phylogenetic Evidence of HIV-1 Transmission Between Adult and Adolescent Men Who Have Sex with Men. (2016) (13)
- The epidemiology of pediatric HIV-1 infection. (1993) (13)
- Associations Between Genital Tract Infections, Genital Tract Inflammation, and Cervical Cytobrush HIV-1 DNA in US Versus Kenyan Women (2013) (12)
- Improved Detection of Rare HIV-1 Variants using 454 Pyrosequencing (2013) (12)
- Plasma From Recovered COVID-19 Patients Inhibits Spike Protein Binding to ACE2 in a Microsphere-Based Inhibition Assay (2020) (12)
- Monotypic low-level HIV viremias during antiretroviral therapy are associated with disproportionate production of X4 virions and systemic immune activation (2018) (12)
- Potential limitation of CCR5 antagonists: drug resistance more often linked to CXCR4-utilizing than to CCR5-utilizing HIV-1 (2008) (12)
- Pseudomonas folliculitis from sponges promoted as beauty aids (1993) (12)
- Correlation between Plasma, Intracellular, and Cervical Tissue Levels of Raltegravir at Steady-State Dosing in Healthy Women (2014) (12)
- HIV-1 RNA Levels and Antiretroviral Drug Resistance in Blood and Non-Blood Compartments from HIV-1–Infected Men and Women enrolled in AIDS Clinical Trials Group Study A5077 (2014) (11)
- Optimization of the oligonucleotide ligation assay for the detection of nevirapine resistance mutations in Zimbabwean Human Immunodeficiency Virus type-1 subtype C. (2014) (11)
- Association of Maternal Viral Load and CD4 Count With Perinatal HIV-1 Transmission Risk During Breastfeeding in the PROMISE Postpartum Component (2021) (11)
- Understanding HIV-1 drug resistance. (2004) (11)
- Simultaneous and sensitive detection of human immunodeficiency virus type 1 (HIV) drug resistant genotypes by multiplex oligonucleotide ligation assay. (2013) (11)
- Histoplasmosis after multiple trauma. (1990) (11)
- Pediatric HIV-1 infection. (1997) (10)
- Polymerase chain reaction diagnosis of primary human herpesvirus-6 infection in the acute care setting. (2006) (10)
- Prednisone improves human immunodeficiency virus encephalopathy in children. (1992) (10)
- Correlation of clinical progression in human immunodeficiency virus-infected children with in vitro zidovudine resistance measured by a direct quantitative peripheral blood lymphocyte assay. (1995) (10)
- Assessment of mitochondrial toxicity by analysis of mitochondrial protein expression in mononuclear cells (2009) (10)
- Increased mutations in Env and Pol suggest greater HIV-1 replication in sputum-derived viruses compared with blood-derived viruses (2009) (10)
- Transmission of nevirapine-resistant HIV type 1 via breast milk to infants after single-dose nevirapine in Beira, Mozambique. (2014) (10)
- Effects of short-course zidovudine on the selection of nevirapine-resistant HIV-1 in women taking single-dose nevirapine. (2012) (10)
- Minority and majority pretreatment HIV-1 drug resistance associated with failure of first-line nonnucleoside reverse-transcriptase inhibitor antiretroviral therapy in Kenyan women. (2019) (10)
- Lack of detection of human immunodeficiency virus type 1 in the saliva of infected children and adolescents. (1997) (10)
- T69D/N pol mutation, human immunodeficiency virus type 1 RNA levels, and syncytium-inducing phenotype are associated with CD4 cell depletion during didanosine therapy. (2002) (9)
- Minority and majority pre-treatment HIV-1 drug resistance associated with failure of 1st-line NNRTI ART in Kenyan women. (2019) (9)
- Planned multiple exposures to autologous virus in HIV type 1-infected pediatric populations increases HIV-specific immunity and reduces HIV viremia. (2008) (9)
- Human immunodeficiency virus drug susceptibility and resistance testing. (2002) (8)
- Transmission of HIV-1 drug resistance mutations within partner-pairs: A cross-sectional study of a primary HIV infection cohort (2018) (8)
- Comment on "The Origins of Sexually Transmitted HIV Among Men Who Have Sex with Men" (2010) (8)
- HIV type 1 zidovudine (ZDV) resistance in blood and uterine cervical secretions of pregnant women. (2006) (8)
- Loss to Follow-Up Among HIV-Exposed Children in an HIV Clinic in Beira, Mozambique (2015) (8)
- Interlaboratory comparison of sequence-specific PCR and ligase detection reaction to detect a human immunodeficiency virus type 1 drug resistance mutation. The AIDS Clinical Trials Group Virology Committee Drug Resistance Working Group (1996) (8)
- Emerging antiretroviral drug resistance in sub-Saharan Africa: novel affordable technologies are needed to provide resistance testing for individual and public health benefits. (2014) (7)
- Near point-of-care, point-mutation test to detect drug resistance in HIV-1: a validation study in a Mexican cohort. (2020) (7)
- Prevention of mother-to-infant transmission of HIV-1. (1997) (6)
- Plasma from recovered COVID19 subjects inhibits spike protein binding to ACE2 in a microsphere-based inhibition assay (2020) (6)
- Selection of HIV Resistance Associated With Antiretroviral Therapy Initiated Due to Pregnancy and Suspended Postpartum (2011) (6)
- Advances in antiviral therapy. (1999) (6)
- Two Clusters of HIV-1 Infection, Rural Idaho, USA, 2008 (2010) (6)
- Structured treatment interruptions (STIs) in HIV-1 infected pediatric populations increases interferon gamma production and reduces viremia. (2008) (6)
- Cost-effectiveness analysis of pre-ART HIV drug resistance testing in Kenyan women (2020) (5)
- Comparison of Matrix-Based and Filter Paper-Based Systems for Transport of Plasma for HIV-1 RNA Quantification and Amplicon Preparation for Genotyping (2016) (5)
- Single-Agent Tenofovir versus Combination Emtricitabine/ Tenofovir for Pre-Exposure Prophylaxis against HIV-1 Acquisition: A Randomized Trial (2014) (5)
- Nevirapine-Resistant HIV-1 DNA in Breast Milk After Single-Dose Nevirapine With or Without Zidovudine for Prevention of Mother-to-Child Transmission. (2012) (5)
- Angiotensin II receptor I auto-antibodies following SARS-CoV-2 infection (2021) (5)
- Passive Transfer of HIV-1 Antibodies and Drug Resistant Virus during a Health Care Worker Accident: Implications for HCW Post-Exposure Management (2008) (4)
- CRISPR/Cas9-Mediated Insertion of HIV Long Terminal Repeat within BACH2 Promotes Expansion of T Regulatory–like Cells (2022) (4)
- Implementation of a point mutation assay for HIV drug resistance testing in Kenya (2018) (4)
- Extensive characterization of HIV-1 reservoirs reveals links to plasma viremia before and during analytical treatment interruption (2021) (4)
- Pretreatment HIV Drug Resistance and Virologic Outcomes to First-Line Antiretroviral Therapy in Peru. (2019) (4)
- Cancer in the HIV-infected child. (1996) (4)
- The Burden of HIV Associated Drug Resistance Mutations in an Early Infant Diagnosis Program: A Glance through the Paediatric Window of Zimbabwe (2016) (4)
- Ethics of HIV research in children. (2015) (4)
- Human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis: Viral load and muscle tone are correlated (2006) (4)
- Genital shedding of human immunodeficiency virus type-1 (HIV) when antiretroviral therapy (ART) suppresses HIV replication in the plasma. (2020) (4)
- Methods used to examine compartmentalization of viral populations between the genital tract and peripheral blood. (2007) (4)
- Comparisons of Human Immunodeficiency Virus Type 1 Envelope Variants in Blood and Genital Fluids near the Time of Male-to-Female Transmission (2019) (3)
- Implementation of an interactive mobile application to pilot a rapid assay to detect HIV drug resistance mutations in Kenya (2021) (3)
- Genetic analyses of HIV env associated with uveitis in antiretroviral-naive individuals (2017) (3)
- Variable and suboptimal nevirapine levels in infants given single-dose nevirapine at birth without maternal prophylaxis. (2014) (3)
- Current management of HIV infection in children. (1993) (3)
- The clinical implications of pretreatment drug resistance -- a moving target. (2018) (3)
- Pediatric AIDS: Clinical, Pathologic, and Basic Science Perspectives. Conference proceedings. Washington, D.C., November 18-21, 1992. (1993) (3)
- Pediatric HIV disease (1997) (3)
- Food insecurity, drug resistance and non-disclosure are associated with virologic non-suppression among HIV pregnant women on antiretroviral treatment (2021) (3)
- Correlates of HIV detection among breastfeeding postpartum Kenyan women eligible under Option B+ (2019) (3)
- Resistance detected by pyrosequencing following zidovudine monotherapy for prevention of HIV-1 mother-to-child-transmission (2015) (3)
- Monitoring of HIV type 1 DNA load and drug resistance in peripheral blood mononuclear cells during suppressive antiretroviral therapy does not predict virologic failure. (2012) (3)
- Impact of Tenofovir-Based Pre-exposure Prophylaxis on Biomarkers of Bone Formation, Bone Resorption, and Bone Mineral Metabolism in HIV-Negative Adults (2019) (3)
- Quantification of mitochondrial toxicity in HIV‐infected individuals by quantitative PCR compared to flow cytometry (2013) (3)
- Rapid, Near Point-of-Care Assay for HLA-B*57:01 Genotype Associated with Severe Hypersensitivity Reaction to Abacavir. (2021) (2)
- Efficacy and Toxicity of Antiretroviral Therapy Using 4 or More Agents: Application of a Strategy for Antiretroviral Management in Human Immunodeficiency VirusInfected Children (2002) (2)
- In-depth characterization of HIV-1 reservoirs reveals links to viral rebound during 1 treatment interruption 2 (2021) (2)
- Maternal HIV drug resistance is associated with vertical transmission and is prevalent in infected infants. (2021) (2)
- Case of concurrent influenza A and Kawasaki disease (2010) (2)
- Isothermal Amplification with a Target-Mimicking Internal Control and Quantitative Lateral Flow Readout for Rapid HIV Viral Load Testing in Low-Resource Settings. (2021) (2)
- Cytomegalovirus gastropathy in a child: resolution after ganciclovir therapy. (1998) (2)
- CD101 genetic variants modify regulatory and conventional T cell phenotypes and functions (2021) (2)
- Development of a novel codon-specific polymerase chain reaction for the detection of CXCR4-utilizing HIV type 1 subtype B. (2013) (2)
- Phylogenetic Analyses Comparing HIV Sequences from Plasma at Virologic Failure to Cervix Versus Blood Sequences from Antecedent Antiretroviral Therapy Suppression. (2019) (2)
- Rapid, Near Point-of-Care Assay for HLA-B*57:01 Genotype Associated with Severe Hypersensitivity Reaction to Abacavir (2021) (2)
- H1N1 influenza vaccination in HIV-infected women on effective antiretroviral treatment did not induce measurable antigen-driven proliferation of the HIV-1 proviral reservoir (2017) (1)
- Impact of CYP2B6 genotype, tuberculosis therapy, and formulation on efavirenz pharmacokinetics in infants and children under 40 months of age (2021) (1)
- HIV Transmission During Condomless Sex With a Seropositive Partner With Suppressed Infection. (2016) (1)
- Development and validation of an oligonucleotide ligation assay to detect lamivudine resistance in hepatitis B virus. (2016) (1)
- Diagnostic Accuracy of Dried Plasma Spot Specimens for HIV-1 Viral Load Testing: A Systematic Review and Meta-analysis (2021) (1)
- Pediatric HIV disease: new developments in treatment and prevention. (1997) (1)
- The In Vitro Growth and Serial Passage of RA 27/3 Rubella Vaccine Virus in Cord Blood Mononuclear Leukocytes from Normal Babies (1995) (1)
- Pandemic ( H 1 N 1 ) 2009 and Oseltamivir Resistance in Hematology / Oncology Patients (2019) (1)
- Blinded, multicenter comparison of methods to detect low frequency drug-resistant HIV-1 variants (2006) (1)
- Issues regarding antiretroviral treatment for patients with HIV-1 infection. (1997) (1)
- Highly active antiretroviral treatment (HAART) of pediatric HIV-1 infection (2004) (1)
- Maternal viral genotypic zidovudine (ZDV) resistance and infrequent failure of ZDV therapy to prevent perinatal transmission (1997) (1)
- Antiretroviral treatment for HIV-infected infants exposed to nevirapine. (2010) (1)
- Association of Virologic Failure and Nonnucleoside Reverse Transcriptase Inhibitor Resistance Found in Antiretroviral-Naive Children Infected With Human Immunodeficiency Virus and Given Efavirenz-Based Treatment. (2019) (1)
- Inexpensive workflow for simultaneous monitoring of HIV viral load and detection of SARS-CoV-2 infection. (2021) (1)
- A Randomized Clinical Trial Evaluating the Management of Pre-Treatment HIV Drug Resistance by Oligonucleotide Ligation Assay (2019) (1)
- Persistent Nonviral Plasmid Vector in Nasal Tissues Causes False-Positive SARS-CoV-2 Diagnostic Nucleic Acid Tests (2022) (1)
- Corrigendum to ‘Simpler and faster Covid-19 testing: Strategies to streamline SARS-CoV-2 molecular assays’ (2021) (0)
- Brief Report: Vaginal Viral Shedding With Undetectable Plasma HIV Viral Load in Pregnant Women Receiving 2 Different Antiretroviral Regimens: A Randomized Clinical Trial (2021) (0)
- Laboratory indicators of mastitis are not associated with elevated HIV-1 DNA or predictive of HIV-1 RNA concentrations in breast milk (2007) (0)
- 279 OPTIMIZATION OF THE OLIGONUCLEOTIDE LIGATION ASSAY, A RAPID AND INEXPENSIVE TEST FOR SUBTYPE B HIV-1 DRUG RESISTANT MUTANTS, FOR NON-SUBTYPE B HIV-1. (2004) (0)
- Addition to "Isothermal Amplification with a Target-Mimicking Internal Control and Quantitative Lateral Flow Readout for Rapid HIV Viral Load Testing in Low-Resource Settings". (2022) (0)
- Low-frequency pre-treatment HIV drug resistance: effects on 2-year outcome of first-line efavirenz-based antiretroviral therapy (2022) (0)
- Monotypic Human Immunodeficiency Virus Type 1 Genotypes across the Uterine Cervix and in Blood Suggest Proliferation of Cells with Provirus (cid:1) (2009) (0)
- Low rate of SARS-CoV-2 incident infection identified by weekly screening PCR in a prospective year-long cohort study (2022) (0)
- Multiple High-Risk HPV Types Contribute to Cervical Dysplasia in Ugandan Women Living With HIV on Antiretroviral Therapy (2022) (0)
- Assessment of minority frequency pretreatment HIV drug-resistant variants in pregnant women and associations with virologic non-suppression at term (2022) (0)
- and S didanosine . associated with resistance to zidovudine and immunodeficiency virus type 1 pol mutations Specific , sensitive , and rapid assay for human (1995) (0)
- Raspopovic modulated by morphogen gradients Digit patterning is controlled by a Bmp-Sox 9-Wnt Turing network (2014) (0)
- Clinical Significance of HIV-1 Drug Resistance Mutations (2006) (0)
- O8 Integration site detection in 10 chronically infected patients (2017) (0)
- Multiple High Risk and Non-Vaccine HPV Types in Ugandan Women Living with HIV on Long-Term Antiretroviral Therapy (2021) (0)
- Implementation of HIV Drug Resistance Testing in Kenya (2016) (0)
- Massively Parallel Sequencing Drug-Resistant Mutants by Use of Immunodeficiency Virus Type 1 Assay for Quantification of Human Validation of an Oligonucleotide Ligation (2014) (0)
- Yet another reason to treat HIV infection. (2012) (0)
- Is increasing pretreatment HIV drug resistance a real menace or minor detail? - Authors' reply. (2020) (0)
- 218: Comparison of venous lactate concentrations in late pregnancy and postpartum: PACTG 1022 (2007) (0)
- Drug Resistance Working Group. AIDS Clinical Trials Group Virology Committee virus type 1 drug resistance mutation. The reaction to detect a human immunodeficiency sequence-specific PCR and ligase detection Interlaboratory comparison of (2013) (0)
- Immunization by exposure to live virus (SIVmne/HIV-2287) during antiretroviral drug prophylaxis may reduce risk of subsequent viral challenge (2021) (0)
- Pediatric human immunodeficiency virus type 1 infection: updates on prevention and management. (2000) (0)
- Mortality Aacross two ART trials enrolling at ≤200 vs ≤350 CD4 cells uL in Kenya (2015) (0)
- HIV RNA level in Anatomic Compartments of Enrolled Men and Women. (2014) (0)
- Persistence of HIV Drug Resistance among South African Children Exposed to Nevirapine Prophylaxis for prevention of Mother-to-Child-Transmission (pMTCT) (2015) (0)
- nevirapine in Beira, Mozambique (2014) (0)
- contributes to persistent infection Proliferation of cells with HIV integrated into cancer genes (2014) (0)
- HIV-1 genotypic resistance and RNA levels in the blood and cervical secretions of pregnant women (1997) (0)
- Short Communication: Analysis of Minor Populations of Human Immunodeficiency Virus by Primer Identification and Insertion-Deletion and Carry Forward Correction Pipelines. (2016) (0)
- Identification and characterization of myeloid-derived suppressor cells in neonates (2011) (0)
- Pediatric human immunodeficiency virus type 1 infection (2000) (0)
- Population pharmacokinetics of oral and intravenous ganciclovir in HIV and CMV infected children (1996) (0)
- Simultaneous monitoring of HIV viral load and screening of SARS-CoV-2 employing a low-cost RT-qPCR test workflow. (2022) (0)
- Characteristics of Enrolled Subjects at Study Enrollment by Sex and History of ART. (2014) (0)
- HIV Transmission Through Premastication. (2022) (0)
This paper list is powered by the following services:
Other Resources About Lisa Frenkel
What Schools Are Affiliated With Lisa Frenkel?
Lisa Frenkel is affiliated with the following schools:
